Dr. Karlawish will review the timeline of events of the development, FDA approval, and post-approval politics of aducanumab.
Back to All Events
Earlier Event: April 25
33rd Annual Issues in Aging Conference
Later Event: May 9
The Problem of Alzheimer's: How a Rare Disease Turned into a Crisis